- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00870701
Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma
Randomised Multicentric Phase III Study Comparing Observation Versus Post-surgery Radiotherapy After Complete Exeresis With Margins Greater Than or Equal to 1 cm in Soft Tissues Members Sarcoma.
Soft tissue sarcomas represent less than 1% of malignant tumors in adults and sarcomas members represent 60% of them.
These rare tumors involve complex multidisciplinary care better in centers having expertise.
Loco-regional therapy strategies have evaluated over time for tumors of members leading to propose more often the combination of a large conservative tumor excision with radiotherapy. Results have been demonstrated equivalent to those of an amputation in terms of local control and survival.
The local recurrence rate for sarcomas of the members of any kind after surgery with or without radiotherapy in the literature varies from 10 to 30%.
The main objective is to achieve a low recurrence rate while maintaining the function. The question remains the possibility of an absence of irradiation in selected cases in a de-escalation therapy order.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
-
Angers, Frankrike, 49933
- Institut de Cancérologie de l'Ouest - Centre Paul Papin
-
Bordeaux, Frankrike, 33076
- Institut Bergonie
-
Caen, Frankrike, 14076
- Centre francois Baclesse
-
Clermont Ferrand, Frankrike, 63011
- Centre Jean Perrin
-
Créteil, Frankrike, 94010
- Hôpital Mondor
-
Lille, Frankrike, 59000
- Centre Oscar Lambret
-
Lyon, Frankrike, 69373
- Centre Leon Berard
-
Marseille, Frankrike, 13385
- CHU de la Timone
-
Marseille, Frankrike, 13273
- Institut Paoli Calmette
-
Montpellier, Frankrike, 34298
- Institut du Cancer de Montpellier - Val d'aurelle
-
Nancy, Frankrike, 54411
- Centre Alexis Vautrin
-
Nice, Frankrike, 06189
- Centre Antoine Lacassagne
-
Rouen, Frankrike, 76038
- Centre Henri Becquerel
-
Saint Herblain (Nantes), Frankrike, 44805
- Institut de Cancérologie de l'Ouest - Centre René Gauducheau
-
Saint-Priest en Jarez, Frankrike, 42270
- Institut de Cancerologie de La Loire
-
Strasbourg, Frankrike, 67065
- Centre Paul Strauss
-
Toulouse, Frankrike, 31052
- Institut Claudius Regaud
-
Villejuif, Frankrike, 94805
- Institut Gustave Roussy
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Soft tissue sarcoma members histologically confirmed
- Tumor primitive complete excision with margins greater than or equal to 10 mm in the soft tissue in all directions during the initial surgery.
A sub-centimeter margin is authorized under an anatomic barrier (fascia, fascia, inter-osseous membrane, periosteum), if surgery is R0 a margin sub-centimeter depth is allowed for superficial tumors if the underlying fascia RESECTED is not invaded.
- Primitive tumors without breaking initial tumor and without tumor residue in the systematic recovery in case of incomplete initial excision margins or doubtful
- WHO less than or equal to 2
- Age greater than or equal to 18 years
- Review extension negative (normal chest CT)
- Information and monitoring possible
- Patient affiliated to social security
Exclusion Criteria:
- Previously treated local sarcoma relapse
- Visceral or lymph node metastases
- pre-operative treatment (chemotherapy or radiotherapy)
- PNET, alveolar rhabdomyosarcoma, Darrier-Ferrand sarcoma
- excision margins of less than 10 mm in one direction or doubtful or unspecified, except under an anatomic barrier (fascia, fascia, inter-osseous membrane, periosteum), if surgery is R0 and tumors if the superficial fascia underlying RESECTED is not invaded.
- Break-tumor during the initial surgery, or residual tumor at second surgery
- Chemotherapy
- Delay between surgery R0 margins greater than or equal to 1 cm (initial surgery or recovery) and the start of radiotherapy exceeding 8 weeks
- History of radiation on the Member
- History of cancer (except carcinoma in situ of the cervix and basal cell skin cancer or in complete remission for over 5 years)
- Pregnant Women
- Patients under guardianship or curatorship
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Strålbehandling
|
50 grays in 25 fractions of 2 Gys or 50.4 grays in 28 fractions of 1.8 grays
|
Experimentell: Absence of Radiotherapy
No Radiotherapy; Simple monitoring without active treatment
|
absence of radiotherapy
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Evaluation of local control at 5 years after surgery compared with exclusive post-operative radiotherapy for soft tissue tumors of the members who have surgery with wide excision margins greater than or equal to 10 mm.
Tidsram: 2021
|
2021
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Evaluation of the quality of life by questionnaire of quality of life QLCQ30
Tidsram: 2021
|
2021
|
Evaluation of acute and late complications
Tidsram: 2009 to 2021
|
2009 to 2021
|
Overall Survival
Tidsram: 2021
|
2021
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Martine DELANNES, MD, Institut Claudius Regaud
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 08SARC01
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Soft Tissue Sarcoma of Members
-
The Netherlands Cancer InstituteOkändMyxoid Liposarcoma of Soft TissueNederländerna, Storbritannien, Norge, Förenta staterna, Danmark
-
Eva Morava-KoziczHar inte rekryterat ännuSLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationFörenta staterna
-
Hospital Ruber InternacionalRekryteringRefraktär epilepsi | SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationSpanien
Kliniska prövningar på absence of radiotherapy
-
Fundacao ChampalimaudOkänd
-
Memorial Sloan Kettering Cancer CenterAktiv, inte rekryterandeMetastaserande cancerFörenta staterna
-
Cancer Trials IrelandUniversity College Dublin; Technological University DublinRekryteringNSCLC/Oligometastatisk cancer (enkel lungskada)Irland
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZeneca; Thoraxklinik-Heidelberg gGmbHRekrytering
-
Institut Català d'OncologiaRekrytering
-
Centre Georges Francois LeclercAktiv, inte rekryterandeStrålbehandlingFrankrike
-
University Hospital, GhentAvslutadLokalt avancerad och ooperbar, men icke-metastaserande pankreasadenokarcinom eller kolangiokarcinomBelgien
-
Guy's and St Thomas' NHS Foundation TrustRekryteringHuvud- och halscancerStorbritannien
-
Ottawa Hospital Research InstituteAvslutadBukspottkörtelkarcinom Ej resektabelKanada
-
Ottawa Hospital Research InstituteOkänd